JGC
GSK icon

J. Goldman & Co’s GSK GSK Stock Holding History

J. Goldman & Co’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-160,000
Closed -$6.91M – 630
2025
Q3 		$6.91M Buy
+160,000
New +$6.25M 0.17% 162
2025
Q2 		– Sell
-60,000
Closed -$2.32M – 534
2025
Q1 		$2.32M Buy
+60,000
New +$2.2M 0.06% 277
2023
Q4 		– Sell
-122,500
Closed -$4.44M – 390
2023
Q3 		$4.44M Buy
+122,500
New +$4.35M 0.16% 144

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

J. Goldman & Co's GSK Position: Q3 2024 in Review

J. Goldman & Co sold out of GSK (GSK) in Q3 2024, closing a stake of 7,473 shares — an estimated $288K sold.

J. Goldman & Co first reported a position in GSK in Q1 2023 and held it in 2 quarters. The position peaked at $3.85M in Q1 2023. 899 funds tracked by Wall St. Rank hold GSK as of Q3 2024.

  • J. Goldman & Co reported no remaining GSK position as of Q3 2024 after selling out during the quarter.
  • J. Goldman & Co sold 7,473 GSK shares in Q3 2024, an estimated $288K.
  • J. Goldman & Co first reported a position in GSK in Q1 2023 and held it in 2 quarters.
  • J. Goldman & Co's GSK position peaked at $3.85M in Q1 2023.
  • 899 funds tracked by Wall St. Rank held GSK as of Q3 2024.

Based on J. Goldman & Co's 13F filing for Q3 2024, filed 14 Nov 2024.